S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
“No Historic Crash Is Coming, What’s NEXT, Is Much Worse…” (PhD Economist) (Ad)
Shelling kills 1 in Ukraine; Russia wants nuke plant pledges
High oil prices help Saudi Aramco earn $88B in first half
Ship carrying grain for hungry Ethiopia leaves Ukraine
“No Historic Crash Is Coming, What’s NEXT, Is Much Worse…” (PhD Economist) (Ad)
Saudi Aramco's profits already $88B as oil prices stay high
Saudi oil company Aramco's half-year profits reach close to $88 billion after posting a 90% surge in second quarter
Average US gasoline price falls 45 cents to $4.10 per gallon
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
“No Historic Crash Is Coming, What’s NEXT, Is Much Worse…” (PhD Economist) (Ad)
Shelling kills 1 in Ukraine; Russia wants nuke plant pledges
High oil prices help Saudi Aramco earn $88B in first half
Ship carrying grain for hungry Ethiopia leaves Ukraine
“No Historic Crash Is Coming, What’s NEXT, Is Much Worse…” (PhD Economist) (Ad)
Saudi Aramco's profits already $88B as oil prices stay high
Saudi oil company Aramco's half-year profits reach close to $88 billion after posting a 90% surge in second quarter
Average US gasoline price falls 45 cents to $4.10 per gallon
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
“No Historic Crash Is Coming, What’s NEXT, Is Much Worse…” (PhD Economist) (Ad)
Shelling kills 1 in Ukraine; Russia wants nuke plant pledges
High oil prices help Saudi Aramco earn $88B in first half
Ship carrying grain for hungry Ethiopia leaves Ukraine
“No Historic Crash Is Coming, What’s NEXT, Is Much Worse…” (PhD Economist) (Ad)
Saudi Aramco's profits already $88B as oil prices stay high
Saudi oil company Aramco's half-year profits reach close to $88 billion after posting a 90% surge in second quarter
Average US gasoline price falls 45 cents to $4.10 per gallon
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
“No Historic Crash Is Coming, What’s NEXT, Is Much Worse…” (PhD Economist) (Ad)
Shelling kills 1 in Ukraine; Russia wants nuke plant pledges
High oil prices help Saudi Aramco earn $88B in first half
Ship carrying grain for hungry Ethiopia leaves Ukraine
“No Historic Crash Is Coming, What’s NEXT, Is Much Worse…” (PhD Economist) (Ad)
Saudi Aramco's profits already $88B as oil prices stay high
Saudi oil company Aramco's half-year profits reach close to $88 billion after posting a 90% surge in second quarter
Average US gasoline price falls 45 cents to $4.10 per gallon
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
NASDAQ:MLAB

Mesa Laboratories - MLAB Stock Forecast, Price & News

$196.14
+5.50 (+2.89%)
(As of 08/12/2022 12:00 AM ET)
Add
Compare
Today's Range
$190.00
$196.50
50-Day Range
$182.13
$214.98
52-Week Range
$178.32
$333.42
Volume
51,064 shs
Average Volume
35,852 shs
Market Capitalization
$1.04 billion
P/E Ratio
N/A
Dividend Yield
0.33%
Price Target
N/A

Mesa Laboratories MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Bearish
8.99% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
1.50mentions of Mesa Laboratories in the last 14 days
Based on 5 Articles This Week
Insider Trading
Selling Shares
$1.62 M Sold Last Quarter
Proj. Earnings Growth
24.01%
From $6.08 to $7.54 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.69 out of 5 stars

Medical Sector

1085th out of 1,135 stocks

Process Control Instruments Industry

13th out of 14 stocks

MLAB stock logo

About Mesa Laboratories (NASDAQ:MLAB) Stock

Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in the United States, Europe, the Asia Pacific, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. Its Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enables to automate chemically synthesized peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The company's Calibration Solutions segment designs, manufactures, and markets quality control and calibration products to measure or calibrate temperature, pressure, pH, humidity, and other such parameters used for health and safety purposes in the hospital, medical device manufacturing, pharmaceutical manufacturing, and various laboratory and healthcare environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. Its Clinical Genomics segment develops, manufactures, and sells genetic analysis tools that include MassARRAY system and consumables, including chips, panels, and chemical reagent solutions used by clinical labs to perform genomic clinical testing in several therapeutic areas, such as newborn screenings, pharmacogenetics, and oncology. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.

Mesa Laboratories Stock Up 2.9 %

MLAB Stock opened at $196.14 on Friday. The business has a 50 day moving average of $200.31 and a 200 day moving average of $228.93. The firm has a market cap of $1.04 billion, a PE ratio of -653.78 and a beta of 0.52. Mesa Laboratories has a twelve month low of $178.32 and a twelve month high of $333.42. The company has a quick ratio of 2.29, a current ratio of 2.90 and a debt-to-equity ratio of 0.57.

Mesa Laboratories (NASDAQ:MLAB - Get Rating) last announced its quarterly earnings data on Thursday, August 4th. The medical instruments supplier reported $0.52 EPS for the quarter, missing the consensus estimate of $1.57 by ($1.05). The firm had revenue of $50.45 million for the quarter, compared to analysts' expectations of $52.63 million. Mesa Laboratories had a negative net margin of 0.78% and a positive return on equity of 5.80%. On average, research analysts forecast that Mesa Laboratories will post 7.6 EPS for the current fiscal year.

Mesa Laboratories Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, September 15th. Shareholders of record on Wednesday, August 31st will be issued a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.33%. The ex-dividend date is Tuesday, August 30th. Mesa Laboratories's payout ratio is -213.33%.

Analysts Set New Price Targets

Separately, StockNews.com downgraded Mesa Laboratories from a "hold" rating to a "sell" rating in a report on Friday, August 5th.

Insider Transactions at Mesa Laboratories

In related news, CEO Gary M. Owens sold 1,756 shares of the stock in a transaction on Tuesday, June 21st. The stock was sold at an average price of $188.22, for a total transaction of $330,514.32. Following the sale, the chief executive officer now directly owns 21,640 shares of the company's stock, valued at $4,073,080.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In other Mesa Laboratories news, SVP Brian David Archbold sold 392 shares of the firm's stock in a transaction dated Tuesday, June 21st. The stock was sold at an average price of $188.22, for a total value of $73,782.24. Following the transaction, the senior vice president now directly owns 813 shares of the company's stock, valued at $153,022.86. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Gary M. Owens sold 1,756 shares of the company's stock in a transaction dated Tuesday, June 21st. The shares were sold at an average price of $188.22, for a total transaction of $330,514.32. Following the sale, the chief executive officer now directly owns 21,640 shares of the company's stock, valued at approximately $4,073,080.80. The disclosure for this sale can be found here. Insiders sold 8,062 shares of company stock worth $1,618,881 over the last quarter. 5.50% of the stock is currently owned by insiders.

Receive MLAB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mesa Laboratories and its competitors with MarketBeat's FREE daily newsletter.

MLAB Stock News Headlines

Mesa Laboratories (NASDAQ:MLAB) Downgraded by StockNews.com
Mesa Laboratories goes ex-dividend tomorrow
Mesa Laboratories is Now Oversold (MLAB)
Analysts See 20% Upside For SPSM
Mesa Labs Announces Third Quarter Results
Mesa Labs (MLAB) Q3 Earnings Miss Estimates
Mesa Laboratories: Q3 Earnings Insights
What History Shows Us About 2022 Market Returns
Is Mesa Laboratories (NASDAQ:MLAB) A Risky Investment?
See More Headlines
Receive MLAB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mesa Laboratories and its competitors with MarketBeat's FREE daily newsletter.

MLAB Company Calendar

Ex-Dividend for 6/15 Dividend
5/27/2022
Dividend Payable
6/15/2022
Last Earnings
8/04/2022
Today
8/14/2022
Ex-Dividend for 9/15 Dividend
8/30/2022
Dividend Payable
9/15/2022
Next Earnings (Estimated)
11/03/2022
Fiscal Year End
3/31/2023

Industry, Sector and Symbol

Industry
Process control instruments
Sub-Industry
Electronic Equipment & Instruments
Sector
Medical
Current Symbol
NASDAQ:MLAB
CUSIP
59064R10
Employees
506
Year Founded
N/A

Profitability

Net Income
$1.87 million
Pretax Margin
-1.63%

Debt

Sales & Book Value

Annual Sales
$184.34 million
Cash Flow
$11.25 per share
Book Value
$71.55 per share

Miscellaneous

Free Float
5,025,000
Market Cap
$1.04 billion
Optionable
Not Optionable
Beta
0.52














MLAB Stock - Frequently Asked Questions

How have MLAB shares performed in 2022?

Mesa Laboratories' stock was trading at $328.09 at the start of the year. Since then, MLAB stock has decreased by 40.2% and is now trading at $196.14.
View the best growth stocks for 2022 here
.

When is Mesa Laboratories' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 3rd 2022.
View our MLAB earnings forecast
.

How were Mesa Laboratories' earnings last quarter?

Mesa Laboratories, Inc. (NASDAQ:MLAB) issued its earnings results on Thursday, August, 4th. The medical instruments supplier reported $0.52 EPS for the quarter, missing the consensus estimate of $1.57 by $1.05. The medical instruments supplier earned $50.45 million during the quarter, compared to analysts' expectations of $52.63 million. Mesa Laboratories had a positive trailing twelve-month return on equity of 5.80% and a negative net margin of 0.78%.

How often does Mesa Laboratories pay dividends? What is the dividend yield for Mesa Laboratories?

Mesa Laboratories announced a quarterly dividend on Wednesday, July 6th. Shareholders of record on Wednesday, August 31st will be paid a dividend of $0.16 per share on Thursday, September 15th. This represents a $0.64 annualized dividend and a yield of 0.33%. The ex-dividend date is Tuesday, August 30th.
Read our dividend analysis for MLAB
.

Is Mesa Laboratories a good dividend stock?

Mesa Laboratories (NASDAQ:MLAB) pays an annual dividend of $0.64 per share and currently has a dividend yield of 0.33%.
Read our dividend analysis for MLAB.

What is Gary Owens' approval rating as Mesa Laboratories' CEO?

5 employees have rated Mesa Laboratories Chief Executive Officer Gary Owens on Glassdoor.com. Gary Owens has an approval rating of 51% among the company's employees. This puts Gary Owens in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Mesa Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Mesa Laboratories investors own include NVIDIA (NVDA), Verizon Communications (VZ), Intel (INTC), Alibaba Group (BABA), Altria Group (MO), Micron Technology (MU), Exxon Mobil (XOM), AbbVie (ABBV), Advanced Micro Devices (AMD) and Becton, Dickinson and (BDX).

What is Mesa Laboratories' stock symbol?

Mesa Laboratories trades on the NASDAQ under the ticker symbol "MLAB."

Who are Mesa Laboratories' major shareholders?

Mesa Laboratories' stock is owned by a number of institutional and retail investors. Top institutional shareholders include Conestoga Capital Advisors LLC (9.78%), Royce & Associates LP (5.24%), Kayne Anderson Rudnick Investment Management LLC (2.79%), Principal Financial Group Inc. (2.41%), Northern Trust Corp (1.68%) and Eagle Asset Management Inc. (1.42%). Insiders that own company stock include Brian David Archbold, David M Kelly, Evan Guillemin, Gary M Owens, Gregory Dinoia, John Bradley Schmieder, John James Sullivan, John Sakys and Robert V Dwyer.
View institutional ownership trends
.

How do I buy shares of Mesa Laboratories?

Shares of MLAB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Mesa Laboratories' stock price today?

One share of MLAB stock can currently be purchased for approximately $196.14.

How much money does Mesa Laboratories make?

Mesa Laboratories (NASDAQ:MLAB) has a market capitalization of $1.04 billion and generates $184.34 million in revenue each year. The medical instruments supplier earns $1.87 million in net income (profit) each year or ($0.30) on an earnings per share basis.

How many employees does Mesa Laboratories have?

The company employs 506 workers across the globe.

How can I contact Mesa Laboratories?

Mesa Laboratories' mailing address is 12100 W 6TH AVE, LAKEWOOD CO, 80228. The official website for the company is www.mesalabs.com. The medical instruments supplier can be reached via phone at (303) 987-8000, via email at investorrelations@mesalabs.com, or via fax at 303-987-8989.

This page (NASDAQ:MLAB) was last updated on 8/14/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.